Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Biotech · Bollinger Reversion | UP 100% | Bollinger Reversion — fade moves outside the bands. INSM ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Breakout | DOWN 100% | Breakout — pushing above the prior channel high. INSM ranks #3 of 8 in Biotech (100% bearish percentile, signal -21.8%), so the agent calls it DOWN for the next session. |
| Biotech · 52-Week-High | DOWN 100% | 52-Week-High — proximity to the trailing high. INSM ranks #3 of 8 in Biotech (100% bearish percentile, 45% of its 52-week high), so the agent calls it DOWN for the next session. |
| Biotech · Meta-Ensemble | DOWN 100% | Meta-Ensemble — a blend of this domain's strategies weighted by their recent precision. INSM ranks #3 of 8 in Biotech (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · LightGBM | DOWN 86% | LightGBM — a gradient-boosted model fit on this basket's recent features. INSM ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Low Volatility | DOWN 86% | Low Volatility — the low-volatility anomaly. INSM ranks #4 of 8 in Biotech (86% bearish percentile, annualized volatility 77%), so the agent calls it DOWN for the next session. |
| Biotech · Mean-Reversion | UP 86% | Mean-Reversion — contrarian on the trailing return. INSM ranks #2 of 8 in Biotech (86% bullish percentile, recent move -4.2%, fading it), so the agent calls it UP for the next session. |
| Biotech · SOTA Ensemble | DOWN 86% | SOTA Ensemble — a purged-CV rank ensemble (gradient-boosting + ridge + momentum). INSM ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Momentum Acceleration | UP 71% | Momentum Acceleration — trend speeding up. INSM ranks #3 of 8 in Biotech (71% bullish percentile, signal +11.9%), so the agent calls it UP for the next session. |
| Biotech · Volume Thrust | UP 57% | Volume Thrust — volume-confirmed accumulation. INSM ranks #4 of 8 in Biotech (57% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP | Donchian — position within the Donchian channel. INSM ranks #8 of 8 in Biotech (0% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · MACD | UP | MACD — MACD histogram momentum crossover. INSM ranks #8 of 8 in Biotech (0% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP | Momentum — trailing return (trend-following). INSM ranks #8 of 8 in Biotech (0% bullish percentile, signal -21.8%), so the agent calls it UP for the next session. |
Best agents on INSM (graded record)
| One Month Momentum | 67% | 8/12 correct | DOWN |
| Momentum Agent | 67% | 8/12 correct | DOWN |
| Mean-Reversion Agent | 67% | 8/12 correct | UP |
| Biotech · Low Volatility | 59% | 49/83 correct | DOWN |
| Biotech · 52-Week-High | 58% | 49/84 correct | DOWN |
| Biotech · Meta-Ensemble | 58% | 41/71 correct | DOWN |
| LightGBM Agent | 57% | 4/7 correct | UP |
| Biotech · Dual Momentum | 57% | 42/74 correct | DOWN |
| Biotech · Trend Strength | 57% | 17/30 correct | DOWN |
| Biotech · Breakout | 53% | 24/45 correct | DOWN |
Recent news
| 2026-10-22 | Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release · yf_tkr_INSM |
| 2026-10-20 | 8-K - INSMED Inc (0001104506) (Filer) · sec_edgar_current |
| 2026-10-20 | Insmed Appoints Two New Directors to Its Board · yf_tkr_SNY |
| 2026-10-19 | Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan · yf_tkr_INSM |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。